News & Events CTI Clinical Trial & Consulting Services To Present at OmniComm Innovation Forum

CTI Clinical Trial & Consulting Services To Present at OmniComm Innovation Forum

October 16, 2017

CTI Clinical Trial & Consulting Services To Present at OmniComm Innovation Forum

FOR IMMEDIATE RELEASE [Covington, KY ~ October 16, 2017]

CTI Clinical Trial and Consulting Services (CTI), a global, privately held, full-service contract research organization, will present at the2017 OmniComm Innovation Forum, taking place in Fort Lauderdale, FL October 19-20, 2017. CTI’s Todd Bonta, Associate Director of Data Management, will speak about 'OmniComm Implementation from the CRO Perspective' on Friday afternoon. 

“We’re honored to be presenting at the 2017 OmniComm Innovation Forum, where so many thought leaders in the industry come together to discuss electronic data capture and technology in trials,” according to Bonta. “CTI offers industry leading systems, including OmniComm, as well as an incredibly knowledgable team that has decades of experience in using these systems for complex trials."

CTI is a part of OmniComm's CRO Preferred Program.

Bonta has been with CTI for nearly 15 years, and is currently the Associate Director of Clinical Data Management, responsible for overseeing all global data management processes. He oversees the development of global standard operating proceedures, as well as the performance of other data management staff in planning, database design, and execution of multiple Phase I through IV clinical trials. Bonta holds a Bachelor of Arts in Psychology from the University of Kentucky and a Master of Arts in Experimental Psychology from Morehead State University. Prior to working at CTI, Bonta worked with Kendle International and held positions such as Clinical Data Project Manager, Clinical Programmer/Analyst, and Clinical Data Associate. He has an extensive therapeutic background which includes experience with rare disease, gene therapy, cardiology/vascular diseases, autoimmune diseases, and hematology.

About OmniComm Systems Innovation Forum 2017

OmniComm Systems is delighted to invite you to the Innovation Forum 2017, an event created in collaboration with our customers. This unique, interactive atmosphere makes for a valuable learning experience and provides a great forum to interact, inform and inspire your peers.

For the seventh consecutive year, OmniComm brings together industry thought leaders and life sciences organizations to explore and discuss how innovations in electronic data capture can meet your organization's demanding clinical research and development requirements. As OmniComm continues to live up to our reputation as a leading software solutions provider to the healthcare and life sciences industry, we want to ensure that you will leave with new ideas, strategies and fresh information for optimizing your clinical trials.

About CTI Clinical Trial and Consulting Services

CTI Clinical Trial and Consulting Services is a global, privately held, full-service contract research organization (CRO), delivering a complete spectrum of clinical trial and consulting services throughout the lifecycle of development, from concept to commercialization. CTI’s focused therapeutic approach provides pharmaceutical, biotechnology, and medical device firms with clinical and disease area expertise in rare diseases, regenerative medicine/gene therapy, immunology, transplantation, nephrology, hematology/oncology, neurology, infectious diseases, hepatology, cardiopulmonary, and pediatric populations. CTI also offers a fully integrated multi-specialty clinical research site that conducts phase I-IV trials. CTI has a passion for helping life-changing therapies succeed in chronically and critically ill patient populations. With clinical trial experience across 6 continents, CTI partners with research sites, patients, and sponsors to fulfill unmet medical needs. CTI is headquartered in the Greater Cincinnati, OH area, with operations across North America, Europe, Latin America, and Asia-Pacific. For more information visit

Subscribe to our mailing list

* indicates required